|
1
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
Jul 3–2017.(Epub ahead of print). doi: 10.1177/1010428317714626.
View Article : Google Scholar
|
|
2
|
Li JH, Zhang SW, Liu J, Shao MZ and Chen
L: Review of clinical investigation on recurrence of gastric cancer
following curative resection. Chin Med J (Engl). 125:1479–1495.
2012.PubMed/NCBI
|
|
3
|
Suzuki H and Mori H: Gastric cancer after
Helicobacter pylori eradication. Gan To Kagaku Ryoho.
45:1123–1127. 2018.(In Japanese). PubMed/NCBI
|
|
4
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statham AL, Clark SJ and Kjems J: miRNA-dependent
gene silencing involving Ago2-mediated cleavage of a circular
antisense RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi X, Zhang W, Nian X, Lu X, Li Y, Liu F,
Wang F, He B, Zhao L, Zhu Y, et al: The previously uncharacterized
lncRNA APP promotes prostate cancer progression by acting as a
competing endogenous RNA. Int J Cancer. 146:475–486. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khan S, Ayub H, Khan T and Wahid F:
MicroRNA biogenesis, gene silencing mechanisms and role in breast,
ovarian and prostate cancer. Biochimie. 167:12–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X
and Tai S: LncRNA HOXA-AS2 and its molecular mechanisms in human
cancer. Clin Chim Acta. 485:229–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu M, Wang G, Tian W, Deng Y and Xu Y:
MiRNA-based therapeutics for lung cancer. Curr Pharm Des.
23:5989–5996. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han J, Zhao G, Ma X, Dong Q, Zhang H, Wang
Y and Cui J: CircRNA circ-BANP-mediated miR-503/LARP1 signaling
contributes to lung cancer progression. Biochem Biophys Res Commun.
503:2429–2435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao
W, Quan J and Fan X: CircRNA-5692 inhibits the progression of
hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP
expression. Cell Death Dis. 10:9002019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T,
Sun H, Pan Y, He B and Wang S: CircHIPK3 promotes colorectal cancer
growth and metastasis by sponging miR-7. Cell Death Dis. 9:4172018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ding HX, Xu Q, Wang BG, Lv Z and Yuan Y:
MetaDE-cased analysis of circRNA expression profiles involved in
gastric cancer. Dig Dis Sci. 65:2884–2895. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang JM, Li XJ and Wang J: Circular RNA
circ_0067934 functions as an oncogene in breast cancer by targeting
Mcl-1. Eur Rev Med Pharmacol Sci. 23:9499–9505. 2019.PubMed/NCBI
|
|
15
|
Zou Q, Wang T, Li B, Li G, Zhang L, Wang B
and Sun S: Overexpression of circ-0067934 is associated with
increased cellular proliferation and the prognosis of non-small
cell lung cancer. Oncol Lett. 16:5551–5556. 2018.PubMed/NCBI
|
|
16
|
Liu Q, Zhou Q and Zhong P: circ_0067934
increases bladder cancer cell proliferation, migration and invasion
through suppressing miR-1304 expression and increasing Myc
expression levels. Exp Ther Med. 19:3751–3759. 2020.PubMed/NCBI
|
|
17
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
X, Wei F, Yu W, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu F, Pillman KA, Neilsen CT, Toubia J,
Lawrence DM, Tsykin A, Gantier MP, Callen DF, Goodall GJ and
Bracken CP: Naturally existing isoforms of miR-222 have distinct
functions. Nucleic Acids Res. 45:11371–11385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang GL, Xia XL, Li XL, He FH and Li JL:
Identification and expression analysis of the MSP130-related-2 gene
from Hyriopsis cumingii. Genet Mol Res. 14:4903–4913. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu C, Wang Y, Li A, Zhang J, Xue F and Zhu
L: Overexpressed circ_0067934 acts as an oncogene to facilitate
cervical cancer progression via the miR-545/EIF3C axis. J Cell
Physiol. 234:9225–9232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Q, Lu G, Luo Z, Gui F, Wu J, Zhang D
and Ni Y: CircRNA circ_0067934 promotes tumor growth and metastasis
in hepatocellular carcinoma through regulation of
miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun.
497:626–632. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui XL, Wang XD, Lin SK, Miao CM, Wu M and
Wei JG: Circular RNA circ_0067934 functions as an oncogene in
glioma by targeting CSF1. Eur Rev Med Pharmacol Sci. 23:8449–8455.
2019.PubMed/NCBI
|
|
25
|
Patop IL and Kadener S: circRNAs in
Cancer. Curr Opin Genet Dev. 48:121–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J and Li H: CircRNA circ_0067934
silencing inhibits the proliferation, migration and invasion of
NSCLC cells and correlates with unfavorable prognosis in NSCLC. Eur
Rev Med Pharmacol Sci. 22:3053–3060. 2018.PubMed/NCBI
|
|
27
|
Juríková M, Danihel L, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stevanovic L, Choschzick M, Moskovszky L
and Varga Z: Variability of predictive markers (hormone receptors,
Her2, Ki67) and intrinsic subtypes of breast cancer in four
consecutive years 2015-2018. J Cancer Res Clin Oncol.
145:2983–2994. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boehm EM, Gildenberg MS and Washington MT:
The many roles of PCNA in eukaryotic DNA replication. Enzymes.
39:231–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao M, Ma W and Ma C: Circ_0067934
promotes non-small cell lung cancer development by regulating
miR-1182/KLF8 axis and activating Wnt/β-catenin pathway. Biomed
Pharmacother. 129:1104612020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Simbulan-Rosenthal CM, Dougherty R, Vakili
S, Ferraro AM, Kuo LW, Alobaidi R, Aljehane L, Gaur A, Sykora P,
Glasgow E, et al: CRISPR-Cas9 Knockdown and Induced Expression of
CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis.
Cancers (Basel). 11:E14902019. View Article : Google Scholar
|
|
32
|
Cui F, Wang S, Lao I, Zhou C, Kong H,
Bayaxi N, Li J, Chen Q, Zhu T and Zhu H: miR-375 inhibits the
invasion and metastasis of colorectal cancer via targeting SP1 and
regulating EMT-associated genes. Oncol Rep. 36:487–493. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park GB, Chung YH and Kim D: Induction of
galectin-1 by TLR-dependent PI3K activation enhances
epithelial-mesenchymal transition of metastatic ovarian cancer
cells. Oncol Rep. 37:3137–3145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong
F, Ren D, Ye X, Li C, Wang Y, et al: Circular RNAs function as
ceRNAs to regulate and control human cancer progression. Mol
Cancer. 17:792018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song XL, Huang B, Zhou BW, Wang C, Liao
ZW, Yu Y and Zhao SC: miR-1301-3p promotes prostate cancer stem
cell expansion by targeting SFRP1 and GSK3β. Biomed Pharmacother.
99:369–374. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peng X, Yan B and Shen Y: MiR-1301-3p
inhibits human breast cancer cell proliferation by regulating cell
cycle progression and apoptosis through directly targeting ICT1.
Breast Cancer. 25:742–752. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Zhao Y, Xu M, Zhou F and Yan J:
Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3
may serve as novel biomarkers for colorectal cancer. J BUON.
24:1120–1127. 2019.PubMed/NCBI
|
|
38
|
Sun X, Jin Z, Song X, Wang J, Li Y, Qian
X, zhang Y and Yin Y: Evaluation of KIF23 variant 1 expression and
relevance as a novel prognostic factor in patients with
hepatocellular carcinoma. BMC Cancer. 15:9612015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Y, Chen H, Dong P, Xie G, Zhou Y, Ma
Y, Yuan X, Yang J, Han L, Chen L, et al: KIF23 activated
Wnt/β-catenin signaling pathway through direct interaction with
Amer1 in gastric cancer. Aging (Albany NY). 12:8372–8396. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kato T, Wada H, Patel P, Hu HP, Lee D,
Ujiie H, Hirohashi K, Nakajima T, Sato M, Kaji M, et al:
Overexpression of KIF23 predicts clinical outcome in primary lung
cancer patients. Lung Cancer. 92:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li XL, Ji YM, Song R, Li XN and Guo LS:
KIF23 promotes gastric cancer by stimulating cell proliferation.
Dis Markers. 2019:97519232019. View Article : Google Scholar : PubMed/NCBI
|
